Latest News

Emphasizing the capability to evaluate the spatiotemporal distribution of PET radiotracers, the MIM KineticID software may provide greater quantitative insights into oncologic, cardiovascular and neurological disease management.

For patients undergoing myocardial perfusion PET/CT, a deep learning model demonstrated greater than 83 percent AUCs for classifying those with low- and high-risk coronary artery calcium (CAC) burden, according to new research presented at the SNMMI conference.

In the latest episode of the Molecular Imaging in Focus series, Isabelle Boileau, PhD, discussed preliminary research, presented at the SNMMI conference, which suggests the utility of a novel tau PET imaging agent that may help detect chronic traumatic encephalopathy (CTE) in living patients.

Do you embrace challenges and change or settle and wallow in your diagnostic comfort zone?

For patients with oligometastatic prostate cancer detected with PSMA PET, researchers found that nearly 78 percent of these patients had negative findings on conventional imaging, according to a study presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.

In a recent interview, Shannon Youngblood, EdD, MSRS, CNMT, RT(CT)(ARRT, shared her perspectives on advocacy for nuclear medicine technologists, scope of practice challenges, theranostics and improving access to PET imaging in rural communities.

Catch up on the top radiology content of the past week.

The Cone-Beam CT (CBCT) Perfusion software reportedly provides CT-quality perfusion maps during neurointerventional procedures.

Catch up on the most-well viewed radiology content in May 2026.

Catch up on the most well-viewed video interviews from Diagnostic Imaging in May 2026.

A randomized controlled trial found that combining Disney characters with soothing ambient elements for pediatric MRI reduced anxiety levels by 43 percent in children under 10 years of age.

Emerging CCTA research affirms the importance of going beyond LDL reduction in the evaluation and treatment of patients with chronic coronary syndrome.

The SubtleHD(PET) software reportedly facilitates enhanced image quality, provides improved SUVmax quantitative accuracy and compatibility with all FDA-approved radiotracers.